Eurofins APAL analysis and advice is completely independent, focused on reliable, consistent services adding value to your business. Our independent service extends beyond the lab, ensuring the best advice and decisions are made to maximise productivity, profitability and future sustainability of your land and the environment.
We have a competitive service which offers value for money and flexible testing and reporting options to suit your needs. We also offer education and training services to ensure you and/or your group's knowledge is up to date with the latest scientifically backed practices across the country.
The team at Eurofins APAL are committed to building and developing lasting client relationships, ensuring consistent and reliable responses to all sample or results inquiries.
We have partnerships with a number of research organisations, that drive innovative outcomes, positioning Eurofins APAL at the forefront of research and development.
We are passionate about supporting research and development. The company is actively collaborating and participating in many diverse activities in the RD&E space. For more information, head to the Research page.
In February 2022, Australian Precision Ag Laboratory (APAL) announced the acquisition by Eurofins and joined the world’s largest laboratory network.
Click here to view acquisition press release
About Eurofins
Eurofins is Testing for Life. Eurofins is the global leader in food, environment, pharmaceutical and cosmetic product testing and in AgroSciences.
With 55,000 staff across a decentralised and entrepreneurial network of 900 laboratories in over 50 countries, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of a wide range of products, as well as providing innovative clinical diagnostic testing services and in-vitro diagnostic products.
The Group's objective is to provide its customers with high-quality services, innovative solutions and accurate results on time. Eurofins is ideally positioned to support its clients’ increasingly stringent quality and safety standards and the increasing demands of regulatory authorities as well as the requirements of healthcare practitioners around the world.
Eurofins has grown very strongly since its inception and its strategy is to continue expanding its technology portfolio and its geographic reach. Through R&D and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical chemistry to offer its clients unique analytical solutions.